DYSIS adopted by JPS Heath for Residency Education
JPS Health adopts DYSIS Cervical Imaging for Residency Education
Edinburgh, Scotland – February 13, 2017 – DYSIS Medical, Ltd. announced today that JPS Health Network, a leading innovator in health care in Fort Worth, Texas, purchased the DYSIS Advanced Cervical Imaging System for the Northwest Health Center for Women and Children, which serves as a clinical training site for OB/GYN residents at JPS.
DYSIS is a clinically proven next-generation colposcope used to assess women after an abnormal Pap smear. The DYSIS imaging technology produces an intuitive color-coded map that assists physicians and residents in identifying, documenting and biopsying abnormal areas of the cervix and standardizes the procedure to make it more objective and accurate.
Clinical studies in Europe and the U.S. IMPROVE-COLPO study have demonstrated that when the map is added to a standard exam, detection of high grade disease is substantially increased. In addition, a Global Patient Experience Survey of over 1,000 women has demonstrated that women strongly prefer DYSIS over traditional colposcopic exams.
DYSIS Medical’s CEO, Alastair Atkinson commented, “We are thrilled that another important residency program has adopted DYSIS for its potential to significantly improve quality, digital documentation for patient management, and patient and resident education. JPS joins several hundred other facilities who have purchased DYSIS worldwide, many of which are academic institutions.”
DYSIS Medical Ltd
DYSIS Medical Ltd has its global headquarters in Edinburgh. The company is committed to saving lives through the early detection and diagnosis of disease using biophotonic innovations. It aims to be the global leader in automated optical molecular imaging technologies for medical diagnostic and screening applications. For more information, please visit: www.dysismedical.com.
